CV Sciences PE Ratio 2011-2020 | CVSI

Current and historical p/e ratio for CV Sciences (CVSI) from 2011 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CV Sciences PE ratio as of May 22, 2020 is 0.00.
CV Sciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.094B $0.054B
CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products. It operates primarily in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is based in Las Vegas, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $61.795B 35.07
Takeda Pharmaceutical (TAK) Japan $59.682B 10.46
Astellas Pharma (ALPMY) Japan $30.032B 0.00
Eisai (ESALY) Japan $20.944B 0.00
UCB SA (UCBJF) Belgium $17.183B 0.00
Merck (MKGAF) Germany $14.504B 0.00
Grifols, S.A (GRFS) Spain $14.170B 17.61
Catalent (CTLT) United States $12.163B 47.02
Neurocrine Biosciences (NBIX) United States $11.590B 53.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.633B 0.00
Ionis Pharmaceuticals (IONS) United States $7.589B 40.35
Orion OYJ (ORINY) Finland $6.879B 30.82
IPSEN SA ADR (IPSEY) France $6.412B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.064B 9.71
United Therapeutics (UTHR) United States $5.175B 9.81
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Nektar Therapeutics (NKTR) United States $4.101B 0.00
Evotec AG (EVTCY) Germany $3.888B 0.00
ChemoCentryx (CCXI) United States $3.728B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.632B 396.56
FibroGen (FGEN) United States $3.281B 0.00
PTC Therapeutics (PTCT) United States $3.182B 0.00
Hypermarcas (HYPMY) Brazil $3.153B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.643B 10.86
Sage Therapeutics (SAGE) United States $2.022B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.908B 14.60
Pacira BioSciences (PCRX) United States $1.900B 38.88
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.824B 0.00
Corcept Therapeutics (CORT) United States $1.805B 17.90
Xencor (XNCR) United States $1.796B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.727B 0.00
USANA Health Sciences (USNA) United States $1.706B 17.49
Zogenix (ZGNX) United States $1.659B 0.00
Heron Therapeutics (HRTX) United States $1.653B 0.00
Akebia Therapeutics (AKBA) United States $1.584B 0.00
Karyopharm Therapeutics (KPTI) United States $1.510B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.404B 15.13
Portola Pharmaceuticals (PTLA) United States $1.399B 0.00
Indivior (INVVY) United States $1.399B 17.36
Translate Bio (TBIO) United States $1.286B 0.00
Tilray (TLRY) Canada $1.279B 0.00
Esperion Therapeutics (ESPR) United States $1.202B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.151B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.106B 49.38
ImmunoGen (IMGN) United States $0.896B 0.00
Endo (ENDP) Ireland $0.887B 1.37
BioCryst Pharmaceuticals (BCRX) United States $0.841B 0.00
Collegium Pharmaceutical (COLL) United States $0.773B 0.00
Molecular Templates (MTEM) United States $0.736B 0.00
Aerie Pharmaceuticals (AERI) United States $0.731B 0.00
Ardelyx (ARDX) United States $0.699B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.603B 0.00
Radius Health (RDUS) United States $0.590B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.584B 0.00
Harpoon Therapeutics (HARP) United States $0.570B 0.00
Innate Pharma SA (IPHYF) France $0.555B 0.00
Trillium Therapeutics (TRIL) Canada $0.528B 0.00
Siga Technologies (SIGA) United States $0.486B 0.00
DURECT (DRRX) United States $0.484B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.457B 11.05
Calithera Biosciences (CALA) United States $0.442B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.425B 16.60
Ocular Therapeutix (OCUL) United States $0.385B 0.00
Flexion Therapeutics (FLXN) United States $0.377B 0.00
MEI Pharma (MEIP) United States $0.372B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.360B 0.00
Organogenesis Holdings (ORGO) United States $0.354B 0.00
TherapeuticsMD (TXMD) United States $0.340B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.324B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.307B 0.00
Concert Pharmaceuticals (CNCE) United States $0.300B 0.00
Lannett Co Inc (LCI) United States $0.298B 6.54
Oasmia Pharmaceutical AB (OASMY) Sweden $0.293B 0.00
CASI Pharmaceuticals (CASI) United States $0.271B 0.00
Redhill Biopharma (RDHL) Israel $0.260B 0.00
Rafael Holdings (RFL) United States $0.241B 0.00
Xeris Pharmaceuticals (XERS) United States $0.218B 0.00
VAXART, INC (VXRT) United States $0.216B 0.00
IMV INC (IMV) Canada $0.211B 0.00
OptiNose (OPTN) United States $0.211B 0.00
KalVista Pharmaceuticals (KALV) United States $0.202B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.197B 0.00
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Aquestive Therapeutics (AQST) United States $0.193B 0.00
Jounce Therapeutics (JNCE) United States $0.192B 4.59
PROFOUND MEDICL (PROF) Canada $0.191B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 22.85
Summit Therapeutics (SMMT) United Kingdom $0.133B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.128B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.123B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.123B 0.00
Recro Pharma (REPH) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
PharmAthene (ALT) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.092B 0.00
Sundial Growers (SNDL) Canada $0.091B 0.00
SCYNEXIS (SCYX) United States $0.078B 0.00
CTI BioPharma (CTIC) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Heat Biologics (HTBX) United States $0.071B 0.00
Onconova Therapeutics (ONTX) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Biomerica (BMRA) United States $0.066B 0.00
Nivalis Therapeutics (ALPN) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.060B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
MediWound (MDWD) Israel $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 32.18
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.052B 0.00
Aclaris Therapeutics (ACRS) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 102.54
Lipocine (LPCN) United States $0.047B 0.00
GTx (ONCT) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.044B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.035B 0.00
PolarityTE (PTE) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Mannatechorporated (MTEX) United States $0.033B 6.33
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Cardiome Pharma (CORV) Canada $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Novan (NOVN) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00